Home > Research > Researchers > Professor David Allsop > Publications

Research

Professor David Allsop

Formerly at Lancaster University

1 - 10 out of 154Page size: 10
RSS feed of this list
Sort by: Title
  1. Published

    β(A4)-amyloid protein and parkinsonian dementia complex of Guam

    Gentleman, S. M., Perl, D., Allsop, D., Clinton, J., Royston, M. C. & Roberts, G. W., 5/01/1991, In: Lancet. 337, 8732, p. 55-56 2 p.

    Research output: Contribution to Journal/Magazine › Letter › peer-review

  2. Published

    α-Synuclein interacts with lipoproteins in plasma

    Nouri Emamzadeh, F. & Allsop, D., 10/2017, In: Journal of Molecular Neuroscience . 63, 2, p. 165-172 8 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  3. Published

    α-Synuclein implicated in Parkinson’s disease is present in extracellular biological fluids, including human plasma.

    El-Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Cooper, L. J., Fullwood, N. J., Gibson, M. J., Curran, M. D., Court, J. A., Mann, D. M. A., Ikeda, S-I., Cookson, M. R., Hardy, J. & Allsop, D., 10/2003, In: FASEB Journal. 17, 13, p. 1945-1947 3 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  4. Published

    α-synuclein implicated in Parkinson’s disease catalyses the formation of hydrogen peroxide in vitro.

    Turnbull, S., Tabner, B. J., Moore, S., Davies, Y., El-Agnaf, O. M. A. & Allsop, D., 15/05/2001, In: Free Radical Biology and Medicine. 30, 10, p. 1163-1170 8 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  5. Published

    α-Synuclein and the pathogenesis of Parkinson’s disease.

    Martin, F., Allsop, D., Williamson, S. J. M., Paleologou, K. E. & El-Agnaf, O. M. A., 2004, In: Protein and Peptide Letters. 11, 3, p. 229-237 9 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  6. Published

    Variation in the concentration and regional distribution of magnetic nanoparticles in human brains, with and without Alzheimer’s disease, from the UK

    Hammond, J., Maher, B., Ahmed, I. & Allsop, D., 30/04/2021, In: Scientific Reports. 11, 13 p., 9363.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  7. Published

    Variability of β-amyloid protein deposited lesions in Down's syndrome brains

    Ikeda, S., Tokuda, T., Yanagisawa, N., Kametani, F., Ohshima, T. & Allsop, D., 1994, In: The Tohoku Journal of Experimental Medicine. 174, 3, p. 189-198 10 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  8. Published

    Utilization of a multiple antigenic peptide as a calibration standard in the BAN50 single antibody sandwich ELISA for Aß oligomers

    Kasai, T., Tokuda, T., Taylor, M., Nakagawa, M. & Allsop, D., 8/06/2012, In: Biochemical and Biophysical Research Communications. 422, 3, p. 375-380 6 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  9. Published

    Untangled - peptide-based inhibitors of tau aggregation as a potential treatment for Alzheimer's disease

    Allsop, D., Aggidis, A., Fullwood, N. J., Taylor, M. N., Foulds, P., Vincent, S. & Dale, M., 2018, In: Journal of Prevention of Alzheimer's Disease. 5, Suppl 1, p. S15-S16 2 p.

    Research output: Contribution to Journal/Magazine › Meeting abstract

  10. Published

    Ultrasonic force microscopy for nanomechanical characterization of early and late-stage amyloid-β peptide aggregation

    Tinker-Mill, C., Mayes, J., Allsop, D. & Kolosov, O., 2014, In: Scientific Reports. 4, 7 p., 4004.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

Previous 1 2 3 4 5 6 7 8 ...16 Next

Back to top